Stay up to date:

Jury

Peter Heinrich

Peter Heinrich

Managing Director and Partner at Sinfonie Life Science Management GmbH and Chairman of the Board of Directors at Injex Pharma AG. Peter has a PhD in Biology and Chemistry from the Ludwig-Maximilians Universität in München and is co-founder and chairman of the executive board of BIO-Deutschland, an independent organization representing the interests of the German biotechnology industry. From 2001 to 2009 he was member of European Biopharmaceutical Enterprises (EBE), and its president from 2003 to 2006. He has been a Board Member of EuropaBio since June 2010, and a Member of the Board of Trustees of Bayern Innovativ GmbH. Peter is also a mentor and tutor at the Bavarian Elite Academy, and a member of the Supervisory Board of the University of Augsburg’s MBA program. LinkedIn

Andy Porter

Prof. Andrew Porter

Professor of Medical Biotechnology, University of Aberdeen, Scotland and Director of the Scottish Biologics Facility. Andrew is also the CTO of the biologics company Elasmogen Ltd with programs in ophthalmology, inflammation and oncology. He was the founder and CSO of Haptogen Ltd. until it was acquired, in October 2007, by Wyeth Inc.  In 2005 he was made the Ernst and Young Plc, UK Science and Technology Entrepreneur of the Year.  In 2006 he was became a Fellow of the Royal Society of Edinburgh and a Fellow of the Royal Society of Biology in 2012.  Andrew has been on the Board of NovaBiotics Ltd since 2009.  NovaBiotics recently announced the successful completion of its Phase 2b Cystic Fibrosis trial for Lynovex™ and won EuropaBio’s most innovative SME in 2017.  Outside of bioscience, and with a team of young industry savvy entrepreneurs, Andy has established a portfolio of award winning cocktail bars (top 100 in the world) and opened Langstrane Liquor Ltd in 2015, Aberdeen’s first gin distillery for 100 years.  Andy is a graduate of St Andrew’s University, Scotland. LinkedIn

Paul Rubig

MEP Dr. Paul Rübig

Austrian Member of the European Parliament since 1996, belonging to the European People’s Party (EPP). Paul is a full member of the Committee on Industry, Research and Energy and the Committee on Budgets, and is very active in the field of the small-scale business promotion. He is president of SME Global, a working group of the International Democrat Union (IDU), whose objective it is to support small and medium-sized enterprises and to improve their business environment. Since 2014, he has been the Chairman of STOA (Scientific Technology Options Assessment), an official body of the European Parliament that is supported by external experts such as universities, scientists or research institutes. Last but not least, he is Co-Chairman of the EPP medium-sized businesses in the Steering Committee on the WTO. LinkedIn

Ekaterina Smirnyagina

Ekaterina Smirnyagina

Ekaterina Smirnyagina is a partner with the Capricorn Health-Tech Venture Fund. Prior to this she was with Alta Partners, a US healthcare focused venture firm. Her current and past board memberships include Adocia (Euronext: ADOC.PA), ConfoTherapeutics NV, HalioDx SA, iSTAR Medical SA, Nexstim plc (Nasdaq First North: NXTMH.HE), Ablynx (Euronext: ABLX.BE), Cerenis Therapeutics  (Euronext: CEREN.PA), Innate Pharma (Euronext: IPH.PA) and Kiadis Pharma (Euronext: KDS.AS), as well as InvestEurope (fka EVCA).  She is the current Chair of the VC Council at InvestEurope. Previously Dr. Smirnyagina worked in business development at Genset S.A. and management consulting at the Mitchell Madison Group. She was a postdoctoral fellow in microbiology & immunology at the Stanford University School of Medicine and holds a Ph.D. in cellular & molecular biology from the University of Wisconsin-Madison and a B.Sc. in biochemistry from Moscow State University. LinkedIn

John Brennan cropped filtered

John Brennan

Secretary General of EuropaBio. John has nearly 30 years’ experience in the healthcare sector, the last thirteen of which being spent in the policy environment in Brussels, both working at the European Commission and in European trade associations for the healthcare industry. Prior to coming to Brussels he worked in the Irish National Standards Authority. Born in Ireland, John is a science graduate from Dublin, with added post-graduate studies in quality management and environmental engineering. LinkedIn

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close